Skip to content
Three Yearly Versus Weekly Shots For Weight Control  episode artwork

Dec 18, 2023 1 min

Three Yearly Versus Weekly Shots For Weight Control 

from Dr. Howard Smith Reports Hosted by Howard G. Smith MD, AM

Vidcast: https://www.instagram.com/p/C1A0Gw-r5fJ/ That’s the promise of a new long-acting form of GLP-1 agonist diet drugs developed by bioengineering material science researchers at Stanford University. Placing a larger dose of the drug in a hydrogel depot permits its slow release over an extended period as long as 4 months. This long-acting drug formulation not only benefits those fighting obesity but type 2 diabetics as well. One shot delivers medication over the time that normally requires 42 separate shots. At this time, this system has only been tested in rats, but human trials are expected to begin with several years. Once those are completed, this more convenient dosing alternative could reach you…..someday soon. https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(23)00486-X #semaglutide #depot #extendedrelease #obesity #diabetes

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Three Yearly Versus Weekly Shots For Weight Control 

0:00 1:03

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Dr. Howard Smith Reports?

This episode is 1 minute long.

When was this Dr. Howard Smith Reports episode published?

This episode was published on December 18, 2023.

Can I download this Dr. Howard Smith Reports episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.